You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 816 NT-I7 and hIL-2/TCB2c combination promotes an immune-stimulatory tumor microenvironment that favors anti-tumor efficacy in combination with checkpoint inhibitors

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
816 NT-I7 and hIL-2/TCB2c combination promotes an immune-stimulatory tumor microenvironment that favors anti-tumor efficacy in combination with checkpoint inhibitors

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023138018
Dec 202332010
Jan 20244702
Feb 202434010
Mar 20243208
Apr 202444010
May 20243704
Jun 20243708
Jul 20242106
Aug 20245107
Sep 20244202
Oct 20241606
Nov 20241807
Dec 20241603
Jan 20251806
Feb 2025405
Mar 2025004
Apr 2025105
May 2025005
Jun 2025004
Total5880130